Oner Hakan F, Aslan Güven, Kurtulan Erkan, Uçar Tolga, Saatçi Osman A, Esen Adil A
Department of Ophthalmology, Dokuz Eylül University School of Medicine, Izmir, Turkey.
Urol Int. 2004;73(1):28-30. doi: 10.1159/000078800.
To assess the effect of sildenafil citrate treatment on visual field analysis (VFA) in patients using sildenafil citrate for erectile dysfunction.
In this prospective study on 18 male volunteers with erectile dysfunction, bilateral VFA was performed using the Humphrey 30-2 central standard threshold test. White-on-white (W/W) and blue-on-yellow (B/Y) protocols were used prior to treatment (baseline VFA) and after treatment (repeat VFA) with sildenafil citrate. W/W and B/Y baseline VFA and repeat VFA mean deviations (MD) were compared.
The baseline MD for W/W and B/Y protocols were -1.34 +/- 1.8 and -2.59 +/- 2.1 dB, respectively, whereas the mean repeat MD for W/W and B/Y protocols were -1.79 +/- 2.21 and -2.83 +/- 3.31 dB, respectively. There was no statistically significant difference between W/W and B/Y baseline and repeat VFA with respect to MD (p > 0.05).
Sildenafil citrate causes no significant changes in Humphrey VFA in patients with erectile dysfunction.